Companies: 10,795·Total market cap: $144.5T
QuidelOrtho Corporation

QuidelOrtho Corporation

QDELNASDAQHealthcare● Active
$14.47
+$0.14(+0.97%)
Market Cap$986696334
P/E Ratio
52W High$35.58
52W Low$9.92
SEC Filings

QuidelOrtho Corporation (QDEL) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001906324 · QDEL · NASDAQ · as of Jun 8, 2026

Filing snapshot

469
Total Filings
4
Latest Form
2026-06-02
Most Recent
1991
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001906324 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-19
Fiscal Year End
Feb 19, 2026
Accession No.
0001906324-26-000008
Primary Document
qdel-20251228.htm
Source: data.sec.gov · CIK 0001906324 · Accession 0001906324-26-000008

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-06
8-KCurrent Report
8-K
2026-05-05Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SDSD
SD
2026-05-11
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-07
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-06
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-06
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-06
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-06
View
10-QQuarterly Report
10-Q
2026-05-06
View
8-KCurrent Report
8-K
2026-05-05
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-30
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
ARSARS
ARS
2026-04-27
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-27
View
DEF 14AProxy Statement
DEF 14A
2026-04-27
View
8-KCurrent Report
8-K
2026-04-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-04-08
View
Showing 1–15 of 174 filingsForm 4 / 144 hidden· 469 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001906324  |  Exchange: NASDAQ · Healthcare

QuidelOrtho Corporation (NASDAQ: QDEL) has submitted 469 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1991. As a Healthcare sector company with CIK 0001906324, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is QuidelOrtho Corporation's most comprehensive regulatory disclosure. The most recent QuidelOrtho Corporation 10-K was filed on 2026-02-19 for fiscal year ending 2026. Historical QDEL 10-K annual reports are available from 2022 through 2026.

Investors researching QuidelOrtho Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

QDEL SEC Filings · 8 questions

QuidelOrtho Corporation (QDEL) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 469 filings and access original documents at no cost. QuidelOrtho Corporation's CIK is 0001906324.

QDEL SEC filingsQuidelOrtho Corporation SEC documentsfind QDEL 10-K